PMA supplement
P100046 S002: ATRICURE SYNERGY ABLATION SYSTEM-OLL2, OSL2, ASU, ASB
FDA PMA supplement · 30-Day Notice · AtriCure, Inc.
Key facts
| Original PMA | P100046 |
|---|---|
| Supplement number | S002 |
| Supplement type | 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | ATRICURE SYNERGY ABLATION SYSTEM-OLL2, OSL2, ASU, ASB |
| Generic name | Surgical cardiac ablation device, for treatment of atrial fibrillation |
| Applicant | AtriCure, Inc. |
| Product code | OCM |
| Received date | May 13, 2013 |
| Decision date | Jun 14, 2013 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: